Detalhe da pesquisa
1.
[Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center]. / Brain Health Services: Erfassung des individuellen Demenzrisikos am Kölner Alzheimer Präventionszentrum.
Nervenarzt
; 94(5): 392-399, 2023 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-36881112
2.
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
Alzheimers Dement
; 2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715930
3.
Stress and Alzheimer's disease.
J Neural Transm (Vienna)
; 126(9): 1155-1161, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30788601
4.
[Prevention of cognitive decline and dementia by treatment of risk factors]. / Prävention von kognitivem Abbau und Demenz durch Behandlung von Risikofaktoren.
Nervenarzt
; 90(9): 921-925, 2019 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-31440769
5.
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.
J Neural Transm (Vienna)
; 123(5): 533-40, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032774
6.
Body Concept and Quality of Life in Patients with Idiopathic Dystonia.
Brain Sci
; 10(8)2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731476
7.
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.
Clin Neurophysiol
; 130(6): 1066-1073, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871800
8.
Botulinum toxin in the management of chronic migraine: clinical evidence and experience.
Ther Adv Neurol Disord
; 10(2): 127-135, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382110